Assessing Online Interventions for Men's' Mental Health and Wellbeing
27 de janeiro de 2022 atualizado por: Jodi Jacobson Frey, University of Maryland, Baltimore
The purpose of this study is to test a comprehensive, male-oriented, online screening and referral (Screening for Mental Health; SMH) and male-oriented online information and referral intervention program (Man Therapy; MT) to improve mental health and wellbeing with a focus on prevention of suicide and help-seeking behaviors among middle-aged men.
The online programs will be offered together to maximize the effect on reducing suicide behavior and increasing mental health help-seeking behaviors for men.
If successful in decreasing suicide behavior and ideation and increasing suicide help-seeking behavior, this intervention could be scaled up to contribute to a reduction in suicide behaviors and deaths across the country.
Visão geral do estudo
Status
Concluído
Condições
Tipo de estudo
Intervencional
Inscrição (Real)
554
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- University of Maryland Baltimore
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
25 anos a 64 anos (Adulto)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Macho
Descrição
Inclusion Criteria:
- men living in Michigan;
- 25-64 years of age at time of enrollment;
- scoring in the moderate- to high-risk range (or answering positively on Question 9) on the Harvard Department of Psychiatry/NDSD Scale (HANDS), scoring in the moderate- to high-risk range for anger on the DSM-5 Level 1 Cross-Cutting Symptom Measure, or identifying any risk for suicide ideation or behavior on the Columbia-Suicide Severity Rating Sale (C-SSRS); and
- fluent in reading English
Exclusion Criteria:
- females
- scoring in the low risk range on the Harvard Department of Psychiatry/NDSD Scale (HANDS), scoring in the low risk range for anger on the DSM-5 Level 1 Cross-Cutting Symptom Measure, or not identifying any risk for suicide ideation or behavior on the Columbia-Suicide Severity Rating Sale (C-SSRS); and
- not fluent in reading English
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Screening for Mental Health only
Participants in the Screening for Mental Health only (control) group will complete the online depression and suicide screening and receive immediate feedback and referrals.
|
Participants in the Screening for Mental Health (SMH)-only group will complete the online depression and suicide screening and receive immediate feedback and referrals.
|
|
Experimental: Screening for Mental Health & Man Therapy
Participants assigned to Screening for Mental Health & Man Therapy (intervention) group will be offered the Man Therapy program in conjunction with Screening for Mental Health.
|
Participants assigned to Screening for Mental Health, plus Man Therapy (SMH+MT) group will be offered the Man Therapy program in conjunction with Screening for Mental Health.
MT provides online early intervention services designed specifically for men who are at risk for suicide and are less likely to engage in help-seeking behavior.
MT takes an innovative and humorous approach to mental health education and help seeking through a fictional "therapist" named Dr.
Rich Mahogany, who is a no-nonsense "man's man" who informs men about the importance of honest talk about life's challenges in addressing their problems.
The web portal allows review "manly mental health information, facts and tips," explore "man therapies," and view videos of men with lived experience.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
Change in depression symptoms as measured by The HANDS: Harvard Department of Psychiatry National Depression Screening Day Scale
Prazo: Baseline; 2 weeks post randomization; 12 weeks post randomization
|
Baseline; 2 weeks post randomization; 12 weeks post randomization
|
|
Change in suicide risk as measured by the Columbia-Suicide Severity Rating Scale-Screen Version
Prazo: Baseline; 2 weeks post randomization; 12 weeks post randomization
|
Baseline; 2 weeks post randomization; 12 weeks post randomization
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
change in attitudes toward help-seeking behavior as measured by the Attitudes Toward Seeking Professional Help short-form
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in alcohol use/abuse as measured by the Alcohol Use Disorders Identification Test
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in relationship conflicts as measured by the Psychological Aggression Scale
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in financial situation as measured by two items (J1 and J4) of the 2009 National Financial Capability Study, Financial Industry Regulatory Authority
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in social support as measured by the Perceived Social Support and/or Conflict scale
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in interpersonal needs as measured by the Interpersonal Needs Questionnaire
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in drug use/abuse as measured by the National Institute of Drug Abuse Quick Screen
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in physical aggression as measured by the Physical Aggression Index scale
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in help seeking behavior as measured by the Perceived Stigma and Barriers to Care for Psychological Problems scale
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in help seeking behavior as measured by the General Help Seeking Questionnaire
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in physical and mental health as measured by the Healthy Days Measures
Prazo: 2 weeks post randomization; 12 weeks post randomization
|
2 weeks post randomization; 12 weeks post randomization
|
|
change in anger as measures by the DSM-5 Self Rated Level 1 Cross-Cutting Symptom Measure
Prazo: Baseline; 2 weeks post randomization; 12 weeks post randomization
|
Baseline; 2 weeks post randomization; 12 weeks post randomization
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Jodi Jacobson Frey, University of Maryland, Baltimore
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de setembro de 2016
Conclusão Primária (Real)
30 de maio de 2019
Conclusão do estudo (Real)
31 de agosto de 2020
Datas de inscrição no estudo
Enviado pela primeira vez
6 de abril de 2016
Enviado pela primeira vez que atendeu aos critérios de CQ
24 de maio de 2016
Primeira postagem (Estimativa)
27 de maio de 2016
Atualizações de registro de estudo
Última Atualização Postada (Real)
10 de fevereiro de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
27 de janeiro de 2022
Última verificação
1 de janeiro de 2022
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- HP-00066262
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
produto fabricado e exportado dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .